South Wales, March 16 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "Nugenyx" on Jan. 31. The details about the trademark application no. UK00004333191 published in the journal no. 2026/010 (March 6).
Sabri Gazail filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Synthetic peptides for pharmaceutical purposes; Protein synthesis inhibitors; Endogenous antigens; Antibodies; Capsules made of dendrimer-based polymers, for pharmaceuticals; Antigens; Exogenous antigens; Protein supplements; Autoantigens; Antiviral prodrugs; Immunostimulants; Protein supplements for animals; Mycolic acid synthesis inhibitors; RNA synthesis inhibitors; Anti-neoplastic preparations from hormones and antagonists; Neoantigens; Pharmaceutical preparations and substances with anti-inflammatory properties; Immunomodulators; DNA synthesis inhibitors; Anti-cancer preparations from hormones and antagonists; Anti-oxidants comprising enzymes; Whey protein dietary supplements; Food supplements consisting of amino acids; Alkaloids used as analgesics; Anti-inflammatory gels; Amino acid preparations for pharmaceutical use; Pharmaceutical preparations and substances with analgesic properties; Radiotherapeutic hormones; Tumour antigens; Alkaloids used as stimulants; Pharmaceutical preparations containing stem cells; Antitoxins; Immunotherapeutic agents for bacterial infections; Blood protein fractions; Folic acid synthesis inhibitors; Protein dietary supplements.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004333191
Disclaimer: Curated by HT Syndication.
